Cowa LLC decreased its position in shares of Altria Group, Inc. (NYSE:MO – Get Rating) by 7.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,617 shares of the company’s stock after selling 500 shares during the quarter. Cowa LLC’s holdings in Altria Group were worth $267,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of MO. Strategic Asset Management LLC lifted its holdings in Altria Group by 8.6% in the third quarter. Strategic Asset Management LLC now owns 2,769 shares of the company’s stock worth $112,000 after buying an additional 219 shares during the period. Choreo LLC raised its holdings in Altria Group by 0.7% in the second quarter. Choreo LLC now owns 34,044 shares of the company’s stock worth $1,422,000 after purchasing an additional 223 shares in the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors lifted its position in Altria Group by 2.2% during the third quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 10,793 shares of the company’s stock valued at $436,000 after buying an additional 230 shares during the period. Keystone Financial Group lifted its position in Altria Group by 3.5% during the second quarter. Keystone Financial Group now owns 6,785 shares of the company’s stock valued at $283,000 after buying an additional 231 shares during the period. Finally, Tyler Stone Wealth Management boosted its holdings in shares of Altria Group by 0.5% during the 2nd quarter. Tyler Stone Wealth Management now owns 46,025 shares of the company’s stock valued at $1,922,000 after buying an additional 231 shares in the last quarter. Institutional investors and hedge funds own 58.68% of the company’s stock.
Altria Group Trading Up 0.1 %
Shares of MO stock opened at $44.84 on Wednesday. Altria Group, Inc. has a 12-month low of $40.35 and a 12-month high of $57.05. The stock has a market capitalization of $80.36 billion, a P/E ratio of 17.42, a P/E/G ratio of 2.22 and a beta of 0.62. The firm’s 50 day moving average is $45.76 and its 200 day moving average is $44.68.
Altria Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, January 10th. Shareholders of record on Thursday, December 22nd were given a $0.94 dividend. The ex-dividend date of this dividend was Wednesday, December 21st. This represents a $3.76 annualized dividend and a yield of 8.39%. Altria Group’s payout ratio is presently 146.30%.
Wall Street Analyst Weigh In
MO has been the topic of a number of recent research reports. Morgan Stanley upped their price objective on shares of Altria Group from $43.00 to $46.00 and gave the stock an “equal weight” rating in a report on Monday. Cowen increased their price target on shares of Altria Group to $47.00 in a report on Tuesday, November 1st. UBS Group cut shares of Altria Group from a “neutral” rating to a “sell” rating and set a $38.00 price target on the stock. in a report on Thursday, November 10th. StockNews.com upgraded shares of Altria Group from a “hold” rating to a “buy” rating in a report on Thursday, January 19th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $50.00 price target on shares of Altria Group in a report on Monday, October 31st. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $46.91.
About Altria Group
Altria Group, Inc operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton.
- Get a free copy of the StockNews.com research report on Altria Group (MO)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Altria Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altria Group and related companies with MarketBeat.com's FREE daily email newsletter.